5.42
前日終値:
$5.55
開ける:
$5.52
24時間の取引高:
3.60M
Relative Volume:
1.03
時価総額:
$1.32B
収益:
$386.15M
当期純損益:
$-56.39M
株価収益率:
-23.57
EPS:
-0.23
ネットキャッシュフロー:
$-55.19M
1週間 パフォーマンス:
-7.51%
1か月 パフォーマンス:
+2.46%
6か月 パフォーマンス:
+35.84%
1年 パフォーマンス:
+5.86%
Ardelyx Inc Stock (ARDX) Company Profile
ARDX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
ARDX
Ardelyx Inc
|
5.42 | 1.35B | 386.15M | -56.39M | -55.19M | -0.23 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.76 | 107.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
755.90 | 77.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
436.38 | 58.90B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
918.92 | 56.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
198.76 | 42.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
Ardelyx Inc Stock (ARDX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-09-03 | 再開されました | Raymond James | Strong Buy |
| 2025-06-18 | 再開されました | H.C. Wainwright | Buy |
| 2025-05-02 | ダウングレード | Raymond James | Strong Buy → Outperform |
| 2025-03-07 | 再開されました | Ladenburg Thalmann | Buy |
| 2025-03-04 | 開始されました | BTIG Research | Buy |
| 2024-11-11 | ダウングレード | H.C. Wainwright | Buy → Neutral |
| 2024-07-02 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2024-04-05 | 開始されました | Leerink Partners | Outperform |
| 2023-12-18 | 開始されました | Raymond James | Strong Buy |
| 2023-09-07 | 開始されました | H.C. Wainwright | Buy |
| 2023-08-25 | アップグレード | Cantor Fitzgerald | Neutral → Overweight |
| 2023-03-03 | アップグレード | Wedbush | Neutral → Outperform |
| 2022-11-17 | アップグレード | Piper Sandler | Neutral → Overweight |
| 2022-05-06 | ダウングレード | Cantor Fitzgerald | Overweight → Neutral |
| 2021-12-01 | アップグレード | Ladenburg Thalmann | Neutral → Buy |
| 2021-10-14 | ダウングレード | Ladenburg Thalmann | Buy → Neutral |
| 2021-07-21 | ダウングレード | Jefferies | Buy → Hold |
| 2021-07-20 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2021-07-20 | ダウングレード | Wedbush | Outperform → Neutral |
| 2021-03-23 | 開始されました | Wedbush | Outperform |
| 2021-01-06 | 開始されました | Cantor Fitzgerald | Overweight |
| 2020-10-20 | 再開されました | Citigroup | Buy |
| 2020-02-18 | 再開されました | Jefferies | Buy |
| 2020-02-12 | 開始されました | Citigroup | Buy |
| 2020-02-10 | 開始されました | Cowen | Outperform |
| 2019-04-08 | 開始されました | Piper Jaffray | Overweight |
| 2018-08-24 | 開始されました | Jefferies | Buy |
| 2018-03-19 | 再開されました | Leerink Partners | Outperform |
| 2017-11-29 | 繰り返されました | Citigroup | Buy |
| 2017-11-22 | 繰り返されました | Ladenburg Thalmann | Buy |
| 2017-10-17 | 再開されました | Leerink Partners | Outperform |
| 2016-03-31 | 開始されました | Ladenburg Thalmann | Buy |
| 2016-03-09 | 開始されました | Cantor Fitzgerald | Buy |
| 2016-03-03 | 開始されました | Citigroup | Buy |
すべてを表示
Ardelyx Inc (ARDX) 最新ニュース
How Ardelyx Inc. stock reacts to job market dataIndex Update & Proven Capital Preservation Methods - newser.com
Is Ardelyx Inc. (41X) stock ideal for retirement investorsMarket Activity Recap & Technical Analysis for Trade Confirmation - newser.com
Will Ardelyx Inc. stock gain from government policiesJuly 2025 Review & AI Enhanced Trade Execution Alerts - newser.com
How Ardelyx Inc. stock valuations compare to rivalsDollar Strength & Long-Term Capital Growth Strategies - newser.com
Combining machine learning predictions for Ardelyx Inc.July 2025 Outlook & Short-Term Trading Alerts - newser.com
What momentum indicators show for Ardelyx Inc. stockJuly 2025 Drop Watch & Fast Entry High Yield Stock Tips - newser.com
Will Ardelyx Inc. stock deliver shareholder valueQuarterly Profit Report & Risk Controlled Swing Alerts - newser.com
Why institutional investors increase stakes in Ardelyx Inc. (41X) stockPortfolio Gains Report & Daily Growth Stock Investment Tips - newser.com
Is Ardelyx Inc. forming a bottoming baseWeekly Trade Analysis & Accurate Buy Signal Alerts - newser.com
What high frequency data says about Ardelyx Inc.Portfolio Performance Report & Advanced Swing Trade Entry Alerts - newser.com
Why Ardelyx Inc. stock is recommended by analystsPortfolio Update Summary & Proven Capital Preservation Methods - newser.com
ARDX: IBSRELA and XPHOZAH drive growth, with profitability and new pipeline assets expected by 2026 - TradingView
Ardelyx at Jefferies London Healthcare: Strategic Growth and Challenges By Investing.com - Investing.com Canada
Ardelyx (ARDX): Evaluating Valuation After Upward Guidance Following Strong IBSRELA Sales Growth - simplywall.st
Applying big data sentiment scoring on Ardelyx Inc.Trade Risk Summary & Technical Pattern Based Signals - newser.com
Ardelyx Shares Surge After Regulatory Wins But Is the Stock Fully Priced in 2025? - Yahoo Finance
News impact scoring models applied to Ardelyx Inc.Swing Trade & Weekly Top Performers Watchlists - newser.com
Will Ardelyx Inc. (41X) stock keep high P E multiplesJuly 2025 Catalysts & Free High Accuracy Swing Entry Alerts - newser.com
Can Ardelyx’s (ARDX) Updated IBSRELA Outlook Reveal More About Its Long-Term Growth Potential? - Yahoo Finance
A Look at Ardelyx (ARDX) Valuation Following Real-World XPHOZAH Study Results at Kidney Week - Yahoo Finance
Ardelyx Inc (ARDX) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):